文献速递妇科

行政健康数据用于子宫内膜异位症诊断识别的验证

Validation of administrative health data for the identification of endometriosis diagnosis.
PubMed 文献 · Hum Reprod · 2025-01-01

本研究将ENDO研究犹他手术队列412名参与者与犹他人口数据库的行政健康数据链接,比较行政健康数据ICD-9编码与手术确诊的子宫内膜异位症诊断。总体灵敏度0.88、特异度0.87、Kappa=0.74,深层浸润型子宫内膜异位症灵敏度仅0.12、Kappa=0.17、特异度0.99。

要点

  • 行政健康数据与手术确诊的子宫内膜异位症总体一致性较高(Kappa=0.74)。
  • 浅表型和卵巢子宫内膜瘤亚型的灵敏度和特异度均较高。
  • 深层浸润型子宫内膜异位症灵敏度低(0.12),行政数据标注不可靠。

核心结论

  • 行政健康数据与手术确诊的子宫内膜异位症总体及浅表型、卵巢子宫内膜瘤亚型存在较高一致性。
  • 深层浸润型子宫内膜异位症在行政健康数据中灵敏度和一致性低、特异度高,标注不可靠。

研究设计与样本

  • 验证研究,纳入ENDO研究犹他手术队列参与者412名,年龄18-44岁、既往无子宫内膜异位症诊断、因各种手术指征接受妇科腹腔镜或开腹手术。
  • 将参与者与犹他人口数据库链接,比较行政健康数据ICD编码与手术确诊的子宫内膜异位症诊断。

主要发现

  • 173名女性基于手术可视化确诊子宫内膜异位症,其中35%为浅表型、9%为卵巢子宫内膜瘤、14%为深层浸润型。
  • 总体子宫内膜异位症诊断灵敏度0.88、特异度0.87、Kappa=0.74。
  • 浅表型子宫内膜异位症(n=143)灵敏度0.86、特异度0.83、Kappa=0.65。
  • 卵巢子宫内膜瘤(n=38)灵敏度0.82、特异度0.92、Kappa=0.58。
  • 深层浸润型子宫内膜异位症(n=58)灵敏度0.12、Kappa=0.17、特异度0.99。

临床怎么用

  • 作者认为,这些发现可为使用行政健康记录评估子宫内膜异位症危险因素和长期健康结局的研究者提供信心。
  • 作者指出,基于病历的深层浸润型子宫内膜异位症诊断可能适用于病因学研究,但不适用于监测或检测研究。

局限性

  • 本研究使用的犹他人口数据库数据未纳入药物处方数据和非结构化数据(如临床笔记),这些额外数据类型可能有助于检测子宫内膜异位症。
  • 大多数参与者为白人或不具有西班牙裔族群的亚洲人(西班牙裔族群报告率为11%),可能限制对其他美国州的推广性。
  • 参与者同时是ENDO研究的一部分,外科医生可能因填写ENDO研究手术表格而在诊断编码时更加警惕,可能提高了有效性;但犹他人口数据库中比较的编码由医疗编码员作为标准临床实践的一部分录入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How do endometriosis diagnoses and subtypes reported in administrative health data compare with surgically confirmed disease? SUMMARY ANSWER: For endometriosis diagnosis, we observed substantial agreement and high sensitivity and specificity between administrative health data-International Classification of Diseases (ICD) 9 codes-and surgically confirmed diagnoses among participants who underwent gynecologic laparoscopy or laparotomy. WHAT IS KNOWN ALREADY: Several studies have assessed the validity of self-reported endometriosis in comparison to medical record reporting, finding strong confirmation. We previously reported high inter- and intra-surgeon agreement for endometriosis diagnosis in the Endometriosis, Natural History, Diagnosis, and Outcomes (ENDO) Study. STUDY DESIGN, SIZE, DURATION: In this validation study, participants (n = 412) of the Utah operative cohort of the ENDO Study (2007-2009) were linked to medical records from the Utah Population Database (UPDB) to compare endometriosis diagnoses from each source. The UPDB is a unique database containing linked data on over 11 million individuals, including statewide ambulatory and inpatient records, state vital records, and University of Utah Health and Intermountain Healthcare electronic healthcare records, capturing most Utah residents. PARTICIPANTS/MATERIALS, SETTING, METHODS: The ENDO operative cohort consisted of individuals aged 18-44 years with no prior endometriosis diagnosis who underwent gynecologic laparoscopy or laparotomy for a variety of surgical indications. In total, 173 women were diagnosed with endometriosis based on surgical visualization of disease, 35% with superficial endometriosis, 9% with ovarian endometriomas, and 14% with deep infiltrating endometriosis. Contemporary administrative health data from the UPDB included ICD diagnostic codes from Utah Department of Health in-patient and ambulatory surgery records and University of Utah and Intermountain Health electronic health records. MAIN RESULTS AND THE ROLE OF CHANCE: For endometriosis diagnosis, we found relatively high sensitivity (0.88) and specificity (0.87) and substantial agreement (Kappa [Κ] = 0.74). We found similarly high sensitivity, specificity, and agreement for superficial endometriosis (n = 143, 0.86, 0.83, Κ = 0.65) and ovarian endometriomas (n = 38, 0.82, 0.92, Κ = 0.58). However, deep infiltrating endometriosis (n = 58) had lower sensitivity (0.12) and agreement (Κ = 0.17), with high specificity (0.99). LIMITATIONS, REASONS FOR CAUTION: Medication prescription data and unstructured data, such as clinical notes, were not included in the UPDB data used for this study. These additional data types could aid in detection of endometriosis. Most participants were white or Asian with Hispanic ethnicity reported 11% of the time, which may limit generalizability to some US states. Additionally, given that participants whose administrative health records we utilized were also part of the ENDO Study, the surgeons may have been more vigilant in diagnostic coding due to the operative forms they completed for the ENDO Study, which may have led to increased validity. However, the codes compared in the UPDB would have been entered by medical coders as part of standard clinical practice. WIDER IMPLICATIONS OF THE FINDINGS: We observed substantial agreement between administrative health data and surgically confirmed endometriosis diagnoses overall, and for superficial and ovarian endometrioma subtypes. These findings may provide reassurance to researchers using administrative healthcare records to assess risk factors and long-term health outcomes of endometriosis. Our findings corroborate prior research that demonstrates high specificity but low sensitivity for deep infiltrating endometriosis, indicating deep infiltrating endometriosis is not reliably annotated in administrative healthcare data. This suggests that medical record-based deep infiltrating endometriosis diagnoses may be suitable for etiologic studies but not for surveillance or detection studies. STUDY FUNDING/COMPETING INTEREST(S): The original ENDO Study was funded by the Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health (contracts NO1-DK-6-3428; NO1-DK-6-3427; 10001406-02). We acknowledge partial support for the UPDB through grant P30 CA2014 from the National Cancer Institute, University of Utah and from the University of Utah's program in Personalized Health and Center for Clinical and Translational Science. This research was also supported by the NCRR grant, 'Sharing Statewide Health Data for Genetic Research' (R01 RR021746, G. Mineau, PI) with additional support from the Utah Department of Health and Human Services, University of Utah. Additionally, this research was supported by the Utah Cancer Registry, which is funded by the National Cancer Institute's SEER Program, Contract No. HHSN261201800016I, the US Centers for Disease Control and Prevention's National Program of Cancer Registries, Cooperative Agreement No. NU58DP007131, with additional support from the University of Utah and Huntsman Cancer Foundation. Research reported in this publication was also supported by the National Institutes of Health (Award Numbers R01HL164715 [to L.V.F., K.C.S., and A.Z.P.] and K01AG058781 [to K.C.S.]), by the Huntsman Cancer Institute's Breast and Gynecologic Cancers Center, and by the Doris Duke Foundation's COVID-19 Fund to Retain Clinical Scientists funded by the American Heart Association. A.C.K. was supported by Training Grant Number 5T15LM007124 from the National Library of Medicine to K.E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other sponsors. There are no competing interests among any of the authors. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Kiser AC, Hemmert R, Myrer R, et al. Validation of administrative health data for the identification of endometriosis diagnosis. Hum Reprod. 2025. PMID: 39704741. doi:10.1093/humrep/deae281

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。